PFS and Titan Alpha Team Awarded Contract to Continue Support for VA’s National Oncology Program
Washington, DC – Prometheus Federal Services (PFS) is pleased to announce that it’s joint venture Titan Alpha has been awarded a contract to continue its support for the U.S. Department of Veterans Affairs (VA) National Oncology Program (NOP). Cancer remains the second leading cause of death among Veterans, and Titan Alpha is committed to helping NOP provide cutting-edge cancer care and research services.
With approximately 55,000 new cancer diagnoses among Veterans each year, NOP plays a vital role in ensuring Veterans receive life-saving care. As part of this contract, Titan Alpha will support critical efforts such as engaging historically underrepresented communities in cancer prevention and screening, and expanding access to chemotherapy treatments via community-based outpatient clinics and other clinical settings.
The PFS/Titan Alpha team has expanded the reach of the NOP, engaging a broad audience through channels including White House communications engagements, outreach activities with Veteran Service Organizations, and products like the Emmy-awarding public service announcement on colorectal screening. The team will continue to expand NOP’s impact with high-level engagements, media placements, and social media campaigns.
“With every impression, view, and click, more Veterans will learn about the resources and care available to them, allowing them to take control of their health and well-being. Our goal is to bridge the gap between Veterans and the care they deserve, ensuring that no one is left behind in the fight against cancer,” said Marissa Smith, PFS Project Manager.
Since 2020, the PFS/Titan Alpha team has partnered with NOP, working alongside VA leaders to enhance oncology services and expand clinical care.
“We are honored to continue supporting the NOP’s critical mission,” said Dana Cogar, PFS Vice President. “This partnership allows us to make a direct impact on Veterans’ lives. By expanding access to innovative treatments and focusing on early detection, we’re advancing care while amplifying our efforts through strategic communications. By raising awareness and promoting early detection, Veterans can make informed decisions about their health. Every new diagnosis is a call to action, and we’re committed to ensuring Veterans have the tools and resources to fight back.”
About Titan Alpha
Titan Alpha is a verified Service-Disabled Veteran-Owned Small Business (SDVOSB) joint venture between Prometheus Federal Services (PFS) and Atlas Research. The joint venture has been a trusted partner of the VA since its inception, delivering innovative solutions in healthcare transformation, technology, and quality improvement.
